Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial

Journal of the American College of Cardiology

Volumn 44, Issue 3, 2004, Pages 547-553

  Nikolsky, Eugenia ^a,b   Aymong, Eve D ^a,b   Halkin, Amir ^a,b   Grines, Cindy L ^c   Cox, David A ^d   Garcia, Eulogio ^e   Mehran, Roxana ^a,b   Tcheng, James E ^f   Griffin, John J ^g   Guagliumi, Giulio ^h   Stuckey, Thomas ⁱ   Turco, Mark ^j   Cohen, David A ^k   Negoita, Manuela ^a,b   Lansky, Alexandra J ^a,b   Stone, Gregg W ^a,b  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d Mid Carolina Cardiology   (United States)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^g GlaxoSmithKline   (United States)

^h OSPEDALI RIUNITI   (Italy)

ⁱ MOSES H CONE MEMORIAL HOSPITAL   (United States)

^j WASHINGTON ADVENTIST HOSPITAL   (United States)

^k BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ACUTE HEART INFARCTION; ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; CORONARY STENT; COST; DEVICE; DIAGNOSTIC VALUE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RISK; STRATIFICATION; WORLD HEALTH ORGANIZATION;

AGED; ANEMIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; BLOOD COMPONENT TRANSFUSION; CEREBROVASCULAR ACCIDENT; FEMALE; HEMATOCRIT; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4043099767     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.03.080     Document Type: Article

References (26)

1. J. Berning, F.V. Steensgaard-Hansen, M. Appleyard Prognostication in acute myocardial infarction by early echocardiographic estimation of left ventricular ejection fraction multivariate statistical comparison with a clinical prognostic index and its components Dan Med Bull 39 1992 177 181
2. G.W. Stone, C.L. Grines, K.F Browne Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction a comparison of thrombolytic therapy and primary angioplasty J Am Coll Cardiol 26 1995 66 72
3. F. Naccarella, G. Lepera, A. Rolli Arrhythmic risk stratification of post-myocardial infarction patients Curr Opin Cardiol 15 2000 1 6
4. P.R. Maroko, E. Braunwald Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion Circulation 53 Suppl 3 1976 I162 8
5. P.S. Levy, S.J. Kim, P.K Eckel Limit to cardiac compensation during acute isovolemic hemodilution influence of coronary stenosis Am J Physiol 265 1993 H340 9
6. P.S. Levy, R.L. Quigley, S.A. Gould Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery J Trauma 41 1996 416 423
7. W.C. Wu, S.S. Rathore, Y. Wang, M.J. Radford, H.M. Krumholz Blood transfusion in elderly patients with acute myocardial infarction N Engl J Med 345 2001 1230 1236
8. N. Al Falluji, J. Lawrence-Nelson, J.B. Kostis, C.R. Lacy, R. Ranjan, A.C. Wilson Effect of anemia on 1-year mortality in patients with acute myocardial infarction Am Heart J 144 2002 636 641
9. G.W. Stone, C.L. Grines, D.A Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators N Engl J Med 346 2002 957 966
10. WHO Scientific Group Nutritional Anemias: Report of a WHO Scientific Group 1968 World Health Organization Geneva
11. D.J. Cohen, D.A. Taira, R Berezin Cost-effectiveness of coronary stenting in acute myocardial infarction results from the stent primary angioplasty in myocardial infarction (Stent-PAMI) trial Circulation 104 2001 3039 3045
12. P.R. Dallman, R. Yip, C. Johnson Prevalence and causes of anemia in the United States, 1976 to 1980 Am J Clin Nutr 39 1984 437 445
13. D.J. Fleming, P.F. Jacques, K.L Tucker Iron status of the free-living, elderly Framingham Heart study cohort an iron-replete population with a high prevalence of elevated iron stores Am J Clin Nutr 73 2001 638 646
14. R.C. Becker, M. Terrin, R Ross Comparison of clinical outcomes for women and men after acute myocardial infarction the Thrombolysis In Myocardial Infarction Investigators Ann Intern Med 120 1994 638 645
15. M.K. Chung, M.S. Bosner, J.P. McKenzie, J. Shen, M.W. Rich Prognosis of patients or = 70 years of age with nonQ-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients or = 70 years of age with Q-wave acute myocardial infarction Am J Cardiol 75 1995 18 22
16. K.H. Mak, D.J. Moliterno, C.B Granger Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction GUSTO-I Investigators (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) J Am Coll Cardiol 30 1997 171 179
17. R.D. Anderson, H.D. White, E.M Ohman Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes a substudy of the GUSTO-III trial: Global Use of Strategies To Open occluded coronary arteries Am Heart J 144 2002 81 88
18. M. Shihara, H. Tsutsui, M. Tsuchihashi, H. Tada, S. Kono, A. Takeshita In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction Am J Cardiol 90 2002 932 936
19. P.J. Best, R. Lennon, H.H Ting The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119
20. G.C. Leng, A.J. Lee, F.G Fowkes Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population Int J Epidemiol 25 1996 1172 1181
21. A.J. Lee, G.D. Lowe, M. Woodward, H. Tunstall-Pedoe Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history the Scottish Heart Health study Br Heart J 69 1993 338 342
22. K. Breddin, D. Loew, K. Lechner, K. Oberla, E. Walter The German-Austrian aspirin trial a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group Circulation 62 1980 V63 72
23. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707-14.
24. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
25. J.L. Carson, A. Duff, R.M Poses Effect of anaemia and cardiovascular disease on surgical mortality and morbidity Lancet 348 1996 1055 1060
26. T.B. Horwich, G.C. Fonarow, M.A. Hamilton, W.R. MacLellan, J. Borenstein Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure J Am Coll Cardiol 39 2002 1780 1786